Trial Evaluating an Investigational Agent for Management of Oral Melanoma

Trial Evaluating an Investigational Agent for Management of Oral Melanoma

CURRENTLY ENROLLING

ANIMAL CLINICAL INVESTIGATION STUDY

DESCRIPTION

The Oncology Service is currently enrolling patients in a fully funded clinical trial for dogs with oral melanoma.

ELIGIBILITY CRITERIA

  • Weighs at least 3 kg (6.6 lbs)
  • Diagnosis of Stage III oral melanoma (not confined to lip)
  • At least one measurable lesion with a longest diameter of ≥ 10 mm (≥ 15 mm short axis for lymph node lesions)
  • Prior surgery acceptable (if performed at least 14 days prior to enrollment)if measurable disease remains which meets above criteria
  • No lung metastasis
  • No prior Oncept® melanoma vaccine

Other study inclusion and exclusion criteria apply. The veterinary investigator will decide if the dog is a good candidate for this study after examination.

REQUIREMENTS

Qualified dogs and their owners should expect to stay in the study for approximately 6 months and have 15 scheduled visits at The Oncology Service. Owners will also be required to document study associated observations as appropriate.

FULLY FUNDED STUDY BENEFITS

  • Novel investigational product or placebo
  • Study-related examinations and diagnostics
  • Consultation and rechecks

Owners will receive a $100 Visa e-gift card if their dog enrolls in the study!

Referring veterinarians will receive a $100 Visa e-gift card if they refer a dog that enrolls in the study!

PARTICIPATING HOSPITALS

  • The Oncology Service – Richmond, VA
  • The Oncology Service – Springfield, VA

Interested?

Enroll or request more information below